Fuzikutan cream is indicated for the local treatment of infectious skin diseases caused by bacteria that are sensitive to the action of fusidic acid (see the section “Pharmacodynamics”). The cream is used for the treatment of wet skin diseases.
active substance: fusidic acid
1 g of gel contains 20 mg of fusidic acid
Excipients: carbomer, triethanolamine, isopropyl myristate, polysorbate 20, sodium edetate, methylparaben (E 218), purified water.
FUZIDERM DOSAGE FORM
FUZIDERM MAIN PHYSICAL AND CHEMICAL PROPERTIES:
soft white gel.
Antibiotics and chemotherapy drugs for use in dermatology. ATX code D06A X01
When applied topically, systemic absorption is negligible.
As monotherapy or in combination with systemic therapy, for the treatment of primary or secondary infections of the skin and soft tissues caused by susceptible strains of microorganisms (Staphylococcus aureus, Streptococcus spp., And Corynebacterium minutissimum), including: impetigo, folliculitis, paronychia, sycosis in the area of the beard, erythrasma, acne, infected wounds and burns, infected contact dermatitis, infected with eczema-like dermatitis.
Hypersensitivity to fusidic acid or other components of the drug, skin and soft tissue infections that are insensitive to the drug, for example, Pseudomonas aeruginos.
INTERACTION WITH OTHER DRUGS AND OTHER INTERACTIONS
FEATURES OF APPLICATION
Bacterial resistance has been reported with the use of fusidic acid, applied topically, as with all topical antibiotics, prolonged and repeated use of the gel can increase the risk of contact sensitization and the development of resistance to antibiotics.
Apply the drug to the skin around the eyes with caution, avoiding contact with the gel in the eyes, as this can irritate the conjunctiva.
The drug contains methylparaben (E 218), which can cause allergic reactions (possibly delayed).
General disorders and reactions at the site of application: itching, slight burning sensation, tingling sensation, dermatitis, including contact and eczematous, skin rashes, erythema, pain at the site of application, reactions at the site of application.
From the immune system: hypersensitivity reactions, including skin irritation, burning sensation, conjunctivitis, periorbital edema, angioedema, urticaria.